LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis DOI Open Access

Tijun Xiao,

Yan An,

Lifang Tan

et al.

Oncology Letters, Journal Year: 2024, Volume and Issue: 27(5)

Published: March 22, 2024

Elevated expression of long non-coding RNA homeobox A cluster antisense 2 (lncRNA HOXA-AS2) is known to have prognostic value in various solid tumors. The present meta-analysis aimed comprehensively quantify its significance across a wider spectrum malignancies and provide an updated synthesis evidence that could refine models. To achieve this aim, multiple databases were carefully searched for lncRNA HOXA-AS2-related articles published the past 10 years. Hazard ratios (HRs) or odds (ORs) with 95% confidence intervals (CIs) calculated demonstrate HOXA-AS2 using Stata 15.0 software. function was inferred from associations key clinical outcomes such as lymph node metastasis, distant tumor stage size, which may reflect role biology. In systematic review 454 patients 7 studies, it found high significantly associated shorter overall survival (OS) time cancer (HR=2.14; CI, 1.40-3.27; P<0.001). High also metastasis [odds ratio (OR)=2.06; 1.07-3.99; P=0.032], (OR=2.11; 1.15-3.88; P=0.016), advanced (OR=2.71; 1.50-4.89; P=0.001) larger size (OR=2.02; 0.86-4.78; P=0.006). However, no significant association observed age (OR=1.00; 0.63-1.59; P=0.991) sex (OR=1.55; 0.72-3.34; P=0.258). conclusion, elevated related poor types, osteosarcoma, non-small cell lung papillary thyroid carcinoma, finding further confirmed by study. Specifically, potential lncRNAHOXA-AS2 biomarker assessing stage, risk OS demonstrated. results study indicated not sex, suggesting progression might be independent these factors. This insight direct future research place more focus on relationship between specific types characteristics.

Language: Английский

Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives DOI Creative Commons
Virendra Kumar Yadav, Seshathiri Dhanasekaran, Nisha Choudhary

et al.

Frontiers in Medicine, Journal Year: 2025, Volume and Issue: 12

Published: Jan. 22, 2025

Parkinson’s disease is a progressive neurodegenerative that destroys substantia nigra dopaminergic neurons, causing tremors, bradykinesia, rigidity, and postural instability. Current treatment approaches primarily focus on symptom management, employing pharmacological, non-pharmacological, surgical methods. However, these treatments often result in fluctuating symptoms, side effects, progression. Here, the authors have reviewed emerging field of nanomedicine as promising path for treatment, emphasizing its potential to overcome limitations traditional therapies. Nanomedicine utilizes nanoparticles targeted drug delivery, leveraging their small size high surface area volume ratio cross blood-brain barrier deliver therapeutic agents directly affected brain regions. Various nanoparticles, including lipid-based, polymeric, metallic, carbon-based, shown treatment. Additionally, nanocarrier systems like liposomes, nanogels, dendrimers, solid lipid offer controlled sustained release agents, enhancing bioavailability reducing effects. This review provides insights into pathophysiology disease, highlighting mechanisms neurodegeneration, role alpha-synuclein, disruption pathways. It further discusses application gene therapy conjunction with interventions.

Language: Английский

Citations

5

Exploring extracellular RNA as drivers of chemotherapy resistance in cancer DOI

Yumna Khan,

Md Sadique Hussain, Prasanna Srinivasan Ramalingam

et al.

Molecular Biology Reports, Journal Year: 2025, Volume and Issue: 52(1)

Published: Jan. 21, 2025

Language: Английский

Citations

3

Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies DOI
Disha D. Shah, Mehul R. Chorawala, Neha R. Raghani

et al.

Medical Oncology, Journal Year: 2025, Volume and Issue: 42(4)

Published: March 18, 2025

Language: Английский

Citations

3

Efficient diagnosis of diabetes mellitus using an improved ensemble method DOI Creative Commons

Blessing Oluwatobi Olorunfemi,

Adewale Opeoluwa Ogunde, Ahmad Almogren

et al.

Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)

Published: Jan. 25, 2025

Diabetes is a growing health concern in developing countries, causing considerable mortality rates. While machine learning (ML) approaches have been widely used to improve early detection and treatment, several studies shown low classification accuracies due overfitting, underfitting, data noise. This research employs parallel sequential ensemble ML paired with feature selection techniques boost accuracy. The Pima India Data from the UCI Repository served as dataset. preprocessing included cleaning dataset by replacing missing values column means selecting highly correlated features using forward backward methods. was split into two parts: training (70%), testing (30%). Python for Jupyter Notebook, there were design phases. first phase utilized J48, Classification Regression Tree (CART), Decision Stump (DS) create random forest model. second employed same algorithms alongside methods—XG Boost, AdaBoostM1, Gradient Boosting—using an average voting algorithm binary classification. Evaluation revealed that XG Boosting achieved of 100%, performance metrics including F1 score, MCC, Precision, Recall, AUC-ROC, AUC-PR all equal 1.00, indicating reliable predictions diabetes presence. Researchers practitioners can leverage predictive model developed this work make quick mellitus, which could save many lives.

Language: Английский

Citations

2

A TGF‐β signaling‐related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response DOI Creative Commons
Weiwei Duan, Liting Yang, Jian Liu

et al.

CNS Neuroscience & Therapeutics, Journal Year: 2023, Volume and Issue: 30(4)

Published: Oct. 18, 2023

Abstract Aims The dysregulation of TGF‐β signaling is a crucial pathophysiological process in tumorigenesis and progression. LncRNAs have diverse biological functions are significant participants the regulation tumor pathways. However, clinical value lncRNAs related to glioma currently unclear. Methods Data on glioma's RNA‐seq transcriptome, somatic mutation, DNA methylation data, clinicopathological information were derived from CGGA TCGA databases. A prognostic lncRNA signature was constructed by Cox LASSO regression analyses. TIMER2.0 database utilized deduce immune infiltration characteristics. “ELMER v.2” used reconstruct TF‐methylation‐gene regulatory network. Immunotherapy chemotherapy response predictions implemented TIDE algorithm GDSC database, respectively. In vitro vivo experiments conducted verify results clarify mechanism lncRNA. Results glioma, signaling‐related 15‐lncRNA constructed, including AC010173.1, HOXA‐AS2, AC074286.1, AL592424.1, DRAIC, HOXC13‐AS, AC007938.1, AC010729.1, AC013472.3, AC093895.1, AC131097.4, AL606970.4, HOXC‐AS1, AGAP2‐AS1, AC002456.1. This proved be reliable tool, with high risk indicating an unfavorable prognosis being linked malignant genomic mutation traits. Risk levels associated different landscapes, where indicative macrophage infiltration. addition, also suggested better immunotherapy response. cg05987823 important site progression, AP‐1 transcription factor family participated expression. AGAP2‐AS1 knockdown inhibited proliferation, migration, invasion cells, as well growth downregulating expression NF‐κB ERK 1/2 pathway. Conclusions established which can for judgment, status inference, prediction. plays role

Language: Английский

Citations

37

From protein to immunology: comprehensive insights into Marburg virus vaccines, mechanism, and application DOI

Mohamed J. Saadh,

Faris Anad Muhammad,

Rafid Jihad Albadr

et al.

Archives of Microbiology, Journal Year: 2025, Volume and Issue: 207(4)

Published: March 1, 2025

Language: Английский

Citations

1

Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer DOI
Abdulmalik Saleh Alfawaz Altamimi, M. Arockia Babu, Muhammad Afzal

et al.

Medical Oncology, Journal Year: 2025, Volume and Issue: 42(4)

Published: March 18, 2025

Language: Английский

Citations

1

Advances and applications of hyperthermia in tumor therapy: Mechanisms, techniques, and clinical integration DOI

Cui-Hua Gu,

Jinzhong Zhang, Jinsong Zeng

et al.

International Communications in Heat and Mass Transfer, Journal Year: 2025, Volume and Issue: 164, P. 108895 - 108895

Published: March 29, 2025

Language: Английский

Citations

1

Ketorolac-Based Ester Derivatives as Promising Hits for Malignant Glioma: Synthesis, Brain Cancer Activity, Molecular Docking, Dynamic Simulation and DFT Investigation DOI
Sami Ullah, Aftab Alam,

Zainab Zainab

et al.

Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: unknown, P. 141128 - 141128

Published: Dec. 1, 2024

Language: Английский

Citations

5

Dengue virus infection: how platelet-leukocyte crosstalk shapes thrombotic events and inflammation DOI

Arash Amin,

Farahnaz Nikdoust,

Sepehr Khorram

et al.

Molecular Biology Reports, Journal Year: 2025, Volume and Issue: 52(1)

Published: Jan. 13, 2025

Language: Английский

Citations

0